Status:
UNKNOWN
Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With Dupilumab
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Conjunctival Diseases
Atopic Dermatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to assess the cytokine profile of tears in patients suffering from conjunctivitis versus patients without ocular involvement, when treated with Dupilumab
Eligibility Criteria
Inclusion
- patients with severe atopic dermatitis resistant to main immunosuppressive drugs
- treated with Dupilumab
- with or without conjunctivitis
- postmenopausal women (since minimum 24 months), surgically sterilized women or women on contraception
Exclusion
- \- pregnant or breastfeeding women
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04066998
Start Date
December 1 2019
End Date
August 1 2021
Last Update
November 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.